Nuveen Mid Cap Value A holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Nuveen Mid Cap Value Fund A Class TCMVX
- NAV / 1-Day Return 19.92 / +1.89 %
- Total Assets 1.7B
-
Adj. Expense Ratio
0.800%
- Expense Ratio 0.780%
- Distribution Fee Level Low
- Share Class Type Front Load
- Category Mid-Cap Value
- Investment Style Mid Blend
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 1.35%
- Turnover 28%
USD | NAV as of Jun 12, 2026 | 1-Day Return as of Jun 12, 2026, 12:27 AM GMT+0
Morningstar’s Analysis TCMVX
Will TCMVX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the TCMVX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of TCMVX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 22.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
TD Synnex Corp | 2.98 | 50M | Technology |
Ciena Corp | 2.48 | 41M | Technology |
WESCO International Inc | 2.32 | 39M | Industrials |
Permian Resources Corp Class A | 2.13 | 36M | Energy |
Williams Companies Inc | 2.09 | 35M | Energy |
MKS Inc | 2.07 | 34M | Technology |
Dover Corp | 2.07 | 34M | Industrials |
Digital Realty Trust Inc | 2.06 | 34M | Real Estate |
Allstate Corp | 2.04 | 34M | Financial Services |
Jazz Pharmaceuticals PLC | 2.03 | 34M | Healthcare |
United States